Stroke remains one of the leading causes of long-term disability worldwide, affecting millions each year. Among its most debilitating consequences is gait impairment, which affects over 80% of stroke ...
Bioness Medical, Inc. ("Bioness", or the "Company"), a global leader in functional electrical stimulation (FES) and advanced rehabilitation technologies, today announced that the Company's PoNS® ...
Medical Device Network on MSN
Aurenar wins breakthrough designation for cerebral vasospasm neuromodulation platform
Aurenar’s V-Link system uses transauricular vagus nerve stimulation to modulate brain inflammation in patients that have ...
Bioness Medical’s PoNS System receives FDA 510(k) clearance to treat dynamic gait deficit due to chronic stroke symptoms: Valencia, California Wednesday, July 1, 2026, 17:00 Hrs ...
Aurenar, developer of a non-invasive neuromodulation platform for patients in intensive care, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device ...
Scientists at EPFL have developed an innovative, non-invasive brain stimulation therapy to significantly improve visual function in stroke patients who have suffered vision loss following a stroke.
My brain injury in 2000 affected my balance and gait. Doctors assessed it by asking me to walk across a small room and back again. Aside from that observational method, which would not have apprised ...
This project was supported by contracts between the National Academy of Sciences and the Alzheimer’s Association; Brain Canada Foundation; the Department of Health and Human Services’ Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results